A phase I safety study of NPC-1C: A novel, therapeutic antibody to treat pancreas and colorectal cancers. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors CDP860 is an ...
Leesburg, VA, November 2, 2022—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), metrics derived from dual-energy CT (DECT) can provide insight on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback